๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
BAROPHARM Co., Ltd. (KOSDAQ:0153R0)
South Korea flag South Korea ยท Delayed Price ยท Currency is KRW
6,700.00
-610.00 (-8.34%)
At close: Nov 17, 2026

BAROPHARM Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Revenue
145,03096,72445,53811,591
Revenue Growth
218.48%112.40%292.88%-
Gross Profit
25,37715,57311,1646,923
Operating Income
3,263-3,932-5,451-2,499
Net Income
1,504-9,679-17,522-7,107
Earnings Per Share
159.45-1461.38-2804.61-1141.00
EPS Growth
----

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
Platform Service
17,39311,3777,597
Sales of Health Functional Foods, Etc.
84,10434,6304,094
Connection Adjustment
-4,773-468.56-99.94
Total
96,72445,53811,591

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
24,70115,64327,43812,537
Total Debt
15,55616,1181,1494,046
Net Cash (Debt)
9,144-474.4426,2898,491
Net Cash Growth
-65.22%-209.62%-
Net Cash Per Share
969.75-71.634207.891363.24

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
1,395-6,552-2,453-5,810
Capital Expenditures
-20,587-19,575-106.4-92.1
Free Cash Flow
-19,193-26,127-2,560-5,902
Free Cash Flow Growth
----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Gross Margin
17.50%16.10%24.52%59.73%
Operating Margin
2.25%-4.06%-11.97%-21.56%
Pretax Margin
1.10%-9.98%-38.16%-61.31%
Profit Margin
1.04%-10.01%-38.48%-61.31%
FCF Margin
-13.23%-27.01%-5.62%-50.92%